Candacide Oral Suspension
PDF Leaflet Revision Date: 24 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of candidal infections of the oral cavity.
Dosage (summary)
1-2 ml (100,000-200,000 units) four times daily; may increase to 4-6 ml for severe infections.
Special Populations
- Infants
- Children
- Elderly
Pregnancy & Breastfeeding
Use during pregnancy only if benefits outweigh risks; caution in breastfeeding.
Contraindications
- Hypersensitivity to nystatin or excipients
- Hereditary fructose intolerance
Common side effects
- Hypersensitivity
- Gastrointestinal disturbances
- Rash
Counselling Points
- Shake well before use
- Retain in mouth before swallowing
- Continue for 48 hours after symptoms resolve
Serious warnings
- Not for systemic mycoses
- Discontinue if irritation develops
Important Disclaimer
The Candacide Oral Suspension professional information leaflet below is the property of Ranbaxy Pharmaceutical and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
